AstraZeneca to seek US approval of COVID vaccine in 2nd half

AstraZeneca said it intends to seek U.S. approval for its COVID-19 vaccine later this year, further delaying the application even as the company announced it had already delivered more than 1 billion doses to other countries

Related posts